1 Hr
Source:
الوطن
US Healthcare Polarizes
The article argues that political polarization in the United States has spread to the health sector. The Department of Health and Human Services, led by Robert F. Kennedy Jr., is moving to make it easier to sell unapproved experimental peptide injections and has asked the Food and Drug Administration not to penalize pharmacies that sell them. It warns of potential health risks: the FDA previously listed 12 types of peptides as substances that should not be used in compounded drugs because of risks including allergic reactions, kidney damage, and tumor growth. The article also points to efforts to accelerate research into psychedelic drugs and review ibogaine, with Texas allocating $50 million to study it, while peptide sales topped $2 billion in 2026.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)